LUPKYNIS® achieved significantly earlier reductions in UPCR and significantly higher renal response rates in lupus nephritis patients with high proteinuria, compared to patients treated with mycophenolate mofetil and low-dose steroids… Read More
UBC’s School of Biomedical Engineering (SBME) invites LSBC members to propose a project for our Capstone Design Course, to be undertaken by 4th-year undergraduate student teams from Sept 2023-May 2024, by filling out… Read More
TORONTO, ON — The results of the Digital Health Canada Board of Directors election were announced today at the association’s Annual General Meeting, held virtually. 14 candidates stood for election… Read More
TORONTO, ON — /PRNewswire/ — Gene Biotechnology Enterprises Ltd., also known as Gene Bio Medical, is excited to announce its strategic partnership with the Canadian Hub for Health Intelligence &… Read More
CHK-336 was generally well tolerated in healthy volunteers (HV) who received single doses up to 500 mg and multiple doses up to 60 mg for 14 days Pharmacokinetics (PK) was… Read More
